Bilal Yıldırım | Clinical Neuroscience | Research Excellence Award

Dr. Bilal Yıldırım | Clinical Neuroscience | Research Excellence Award

Dr. Bilal Yıldırım | Marmara University Internal Medicine Department | Turkey

Dr. Bilal Yildirim is a physician–scientist with a strong research focus spanning hematology, oncology, cardiology, and translational clinical medicine. His scholarly work emphasizes molecular mechanisms of disease, prognostic biomarkers, and genomics-guided therapeutic strategies. He has contributed to research on hematologic genetics through investigations of HFE gene mutations in erythrocytosis and has explored systemic inflammatory markers, such as the neutrophil–lymphocyte ratio, as independent prognostic indicators in rare malignancies including chondrosarcoma. His peer-reviewed publication in Brain Sciences presents a comprehensive, genomics-driven, multimodal treatment framework for adult-onset diffuse midline glioma, highlighting precision medicine approaches in neuro-oncology. In addition to conference poster and e-poster presentations at international and national scientific meetings, his academic training and clinical research exposure at major institutions have supported a rigorous approach to evidence-based medicine. His ongoing research trajectory integrates clinical observation with molecular and outcomes-based analysis to advance personalized diagnostics and therapeutics.

View Orcid Profile

Featured Publication


Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach
– Abdussamet Çelebi, Bilal Yıldırım, Emine Yıldırım, Selver Işık, Ezgi Çoban, Erhan Bıyıklı, Osman Köstek, İbrahim Vedat Bayoğlu, Murat Sarı, Brain Sciences

Fiona Jaederlund Fosalba | Clinical Neuroscience | Research Excellence Award

Ms. Fiona Jaederlund Fosalba | Clinical Neuroscience | Research Excellence Award

Ms. Fiona Jaederlund Fosalba | Universidad del Desarollo | Chile

Fiona Jaederlund Fosalba is a medical student and young researcher from Lo Barnechea, Chile, distinguished by her perseverance, discipline, responsibility, and open-minded approach. She has practiced ballet since the age of three, developing exceptional body control and coordination, which sparked her early curiosity about the human body and inspired her vocation for medicine. In parallel, she has worked as an advertising model from a young age, gaining financial independence, professional maturity, and valuable experience in teamwork, while strengthening her ability to manage time efficiently and remain highly organized. Her academic trajectory is marked by active involvement in research projects in dermatology, rheumatology, oncology, and rare diseases, where she has served as a research assistant, first author, and presenter in national and international scientific settings. She has participated regularly in specialized congresses, symposia, and academic meetings, consolidating her clinical and research training. Fiona has also assumed leadership and teaching roles in academic guidance programs, contributing to the development of pre-university students. Her achievements include peer-reviewed scientific publications, awards for academic excellence, and outstanding performance in clinical assessments. Her profile reflects a strong integration of scientific rigor, human sensitivity, early vocational commitment, diverse professional experience, and a sustained dedication to excellence and comprehensive development in the field of health.

View Orcid Profile

Featured Publications

Current and Emerging Biomarkers in Dermatomyositis: Clinical Utility and Future Directions
– Fiona Jaederlund, Ka Wei Katty Joo Hu, Claudio Karsulovic, Lia Hojman, International Journal of Translational Medicine

Enfermedades raras: una mirada biopsicosocial
– Fiona Jaederlund Fosalba, Sofía Norero Rivera, Carla Campaña Castillo, Revista Confluencia

Vishal Chavda | Clinical Neuroscience| Neuroscience Future Leader Award

Dr. Vishal Chavda | Clinical Neuroscience | Neuroscience Future Leader Award

Dr. Vishal Chavda | Department of Neurology, Leonard Miami Miller School of Medicine | India

Dr. Vishal K. Chavda is a distinguished neuroscientist, researcher, and clinician specializing in brain disorders, neurosurgery, stroke, and mental health, with current affiliations at the University of Miami’s Miller School of Medicine, focusing on Interventional Neurology and Endovascular Neurosurgery. He is an accomplished Clinician, Neuroscientist, and Neuro-Spine Disorders expert, internationally recognized for his multidisciplinary contributions to clinical neuroscience, neurosurgical research, and global academic leadership. His work bridges patient-centered clinical insight with high-impact translational and systematic research, positioning him as one of the emerging future leaders in neuroscience.

He holds MS and PhD degrees, has postdoctoral research experience at Stanford Medicine, and is recognized internationally for his work in neuropharmacology, neuro-oncology, and stroke research, receiving awards like the “Asia’s Iconic Scientist Award”. Dr. Chavda has demonstrated exceptional scholarly productivity and scientific influence. To date, he has authored over 110 peer-reviewed international publications, with his work accruing 1,351 citations, an h-index of 20, and an i10-index of 33, reflecting both depth and consistency of academic impact.

His research spans neuro-spine disorders, cerebrovascular disease, stroke, traumatic brain injury, neuro-oncology, neurodegeneration, and advanced neurosurgical techniques, with particular emphasis on evidence synthesis, risk stratification, and outcome-driven clinical frameworks. As a clinician-scientist, Dr. Chavda’s expertise in neuro-spine and neurovascular disorders has informed clinically relevant research that translates directly into improved diagnostic, surgical, and rehabilitative strategies.

His work is widely cited and contributes to shaping contemporary understanding of complex neurosurgical conditions across diverse healthcare settings, including low- and middle-income countries. Beyond journal publications, Dr. Chavda has made significant contributions to academic scholarship as an editor of major international neuroscience and neurosurgery textbooks published by leading academic presses like Elsevier. He serves as Editor and Co-Editor of forthcoming authoritative volumes addressing stroke management and therapeutics, traumatic brain injury rehabilitation, and neurogynecology and associated neurological disorders, further underscoring his role in defining future directions of neuroscientific education and clinical practice.

Dr. Chavda is also an active editorial board member and peer reviewer for numerous high-impact international journals, contributing to the maintenance of scientific rigor and ethical standards in neuroscience research. His leadership in special issues and thematic series reflects his vision for advancing interdisciplinary and globally inclusive neuroscience. Recognized with multiple international honors and scientific awards, Dr. Vishal K. Chavda exemplifies the qualities of a Neuroscience Future Leader, combining clinical excellence, sustained research productivity, editorial leadership, and a strong commitment to global neurosurgical advancement. His ongoing work continues to shape the next generation of neuroscience research and clinical innovation.

Citation Metrics (Google Scholar)

1500
1000
500
0

Citations
1347

Documents
30

h-index
20

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications

Cerebrospinal fluid volume: the overlooked determinant in brain and spinal stroke
– V Chavda, CM Stary, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7956–7957, 2025

Persistent pelvic pain in women: unraveling diagnostic challenges and the overlooked role of pelvic congestion syndrome
– V Chavda, B Joshi, AD Bhatt, S Patel, M Savaliya, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7950–7952, 2025

Redefining Access: A Syringe-Based Tubular Retractor for Minimally Invasive Spine Surgery in Low-Resource Settings
– G Reyes-Soto, DAV Moreno, R Nurmukhametov, V Chavda, SN Comprehensive Clinical Medicine, 7(1), 310, 2025

Preventing spina bifida in low- and middle-income countries: bridging gaps through folic acid fortification and policy reform
– MK Vatse, V Chavda, YB Roka, B Chaurasia, Annals of Medicine and Surgery, 87(10), 6263–6264, 2025

Association between vitamin D deficiency and subarachnoid hemorrhage: a systematic review
– VO da Silva, RP Manicardi, JS Brito, MG de Sena Barbosa, LZ Pipek, V Chavda, Annals of Medicine and Surgery, 87(10), 6443–6450, 2025

Steve Blake | Clinical Neuroscience | Research Excellence Award

Dr. Steve Blake | Clinical Neuroscience | Research Excellence Award

Dr. Steve Blake | Maui Memory Clinic | United States

Steve Blake is a Doctor of Science specializing in nutritional biochemistry and a leading authority in nutritional neuroscience, serving as Director of Nutritional Neuroscience at the Maui Memory Clinic and Research Director at the Neuroscience Nutrition Foundation, where his work bridges clinical research and practical dietary strategies for brain health. He designed and led the Hawaii Dementia Prevention Trial, a landmark clinical study demonstrating the impact of targeted nutrition on cognitive decline, which inspired his influential book Nutrients for Memory. He is the senior author of a widely cited study on diet and dementia in the Journal of Alzheimer’s Disease and lead author of multiple peer-reviewed papers examining the role of diet in neuroinflammation in Alzheimer’s and Parkinson’s diseases. His scholarly impact is reflected in an h-index of 5 with approximately 192 citations across 112 research documents, highlighting sustained contributions to nutrition-based neuroscience. Beyond research, he has delivered widely viewed lectures, taught extensively at the University of Hawaii, and led grand rounds at major hospitals. He has authored sixteen major books on nutrition and health, including Vitamins and Minerals Demystified, Fats and Oils Demystified, Diabetes Breakthrough, and No More Heart Attacks, and served as lead advisor and author for the Gale Encyclopedia of Alternative Medicine, integrating scientific rigor with public education and clinical insight.

Citation Metrics (Google Scholar)

200
150
100
50
0

Citations
192

Documents
112

h-index
5

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications


Medicinal Plant Names. Sample Excerpt
– S. Blake, Retrieved August 12, 2010 (2004)


Reducing dietary lipopolysaccharides to slow progression of cognitive impairment and Alzheimer’s disease
– S. Blake, T. Harding, L. Baroni, M. Harding, C. Blake, P. Piboolnurak, W. Grant, Journal of Brain Sciences, 2024


Reducing excess dietary saturated fat intake to improve cognition in vascular dementia
– S.M. Blake, R. Harding, C.P. Blake, P.L. Borman, GSC Advanced Research and Reviews, 2022


Kidney stone risk reduction and size reduction utilizing medical plants
– S.M. Blake, C. Blake, GSC Biological and Pharmaceutical Sciences, 2022

Vishal Chavda | Clinical Neuroscience| Neuroscience Future Leader Award

Dr. Vishal Chavda | Clinical Neuroscience | Neuroscience Future Leader Award

Dr. Vishal Chavda | Department of Neurology, Miami Miller School of Medicine, Miami | United States

Vishal K. Chavda, Ph.D., M.S., PG.Dip (Clinical Psychology), FICN, MAHA/ASA, is a neuroscientist and neuropharmacologist with multidisciplinary expertise in neurology, neurosurgery, and neuropathology, currently serving as a Postdoctoral Associate in the Department of Neurology, Division of Interventional Neurology and Endovascular Neurosurgery at the University of Miami Miller School of Medicine, and previously as a Postdoctoral Fellow in Neuropathology at Stanford University School of Medicine, with international experience as a Visiting Fellow in Neurosurgery at the Gamma Knife Center, Garibaldi Cannizzaro Hospital, Italy. He earned his Ph.D. in Neuropharmacology from Nirma University and has held prestigious fellowships supported by CSIR, Government of India. His research focuses on ischemic and pediatric stroke, endovascular stem cell therapy, traumatic brain injury, glioblastoma and brain metastasis, neurovascular conflict syndromes and aneurysms, vesicular trafficking in stroke, epilepsy, cognitive decline, neurodegeneration including Alzheimer’s disease, and computational in-silico modeling. Dr. Chavda has authored over 30 peer-reviewed scientific documents, accumulating more than 1,347 citations, with an h-index of 20 and an i10-index exceeding 30, reflecting the strong impact and visibility of his work in clinical and translational neuroscience. He is actively seeking a research or academic position to advance innovative therapies and mechanistic insights in neurovascular and neurodegenerative disorders.

Citation Metrics (Google Scholar)

1500
1000
500
0

Citations
1347

Documents
30

h-index
20

Citations

Documents

h-index

View Google Scholar Profile

Featured Publications

Cerebrospinal fluid volume: the overlooked determinant in brain and spinal stroke
– V Chavda, CM Stary, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7956–7957, 2025

Persistent pelvic pain in women: unraveling diagnostic challenges and the overlooked role of pelvic congestion syndrome
– V Chavda, B Joshi, AD Bhatt, S Patel, M Savaliya, B Chaurasia, Annals of Medicine and Surgery, 87(12), 7950–7952, 2025

Redefining Access: A Syringe-Based Tubular Retractor for Minimally Invasive Spine Surgery in Low-Resource Settings
– G Reyes-Soto, DAV Moreno, R Nurmukhametov, V Chavda, SN Comprehensive Clinical Medicine, 7(1), 310, 2025

Preventing spina bifida in low- and middle-income countries: bridging gaps through folic acid fortification and policy reform
– MK Vatse, V Chavda, YB Roka, B Chaurasia, Annals of Medicine and Surgery, 87(10), 6263–6264, 2025

Association between vitamin D deficiency and subarachnoid hemorrhage: a systematic review
– VO da Silva, RP Manicardi, JS Brito, MG de Sena Barbosa, LZ Pipek, V Chavda, Annals of Medicine and Surgery, 87(10), 6443–6450, 2025

Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Dr. Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Kaiser Permanente of Georgia, Emory School of Medicine | United States

Dr. Joshua I. Barzilay is a senior clinician–scientist and board-certified endocrinologist whose research spans diabetes, hypertension, cardiovascular disease, metabolic syndrome, and aging, integrating epidemiology with long-term clinical outcomes. His early work included oncology and hematology research, followed by a sustained focus on endocrine and metabolic disorders during his tenure at Kaiser Permanente of Georgia and Emory University School of Medicine. Dr. Barzilay has made influential contributions to large, multicenter clinical and population-based studies, including ALLHAT, ACCORD/ACCORDION, and the Cardiovascular Health Study, where he has served on steering committees and specialty working groups. His research has clarified the impact of glucose dysregulation, insulin resistance, and antihypertensive therapies on cardiovascular morbidity, mortality, and incident diabetes, particularly in older adults. A major theme of his work is the relationship between metabolic syndrome, frailty, autonomic function, and cardiovascular risk, providing evidence to guide treatment strategies in complex patients. In addition to his research, Dr. Barzilay has played a key role in national diabetes and hypertension guideline development, medical education, and dissemination of evidence-based care, shaping clinical practice across endocrinology and primary care.

Citation Metrics (Scopus)

25000
20000
15000
10000
0

Citations
24,155

Documents
186
h-index
58

Citations

Documents

h-index


View Scopus Profile
View Google Scholar Profile

Featured Publications

Dmytro Maltsev | Clinical Neuroscience | Best Paper Award

Assoc. Prof. Dr. Dmytro Maltsev | Clinical Neuroscience | Best Paper Award

Assoc. Prof. Dr. Dmytro Maltsev | O’Bogomolets National Medical University |  Ukraine

Maltsev Dmytro is a distinguished neuroimmunologist, clinical researcher, and head of the Immunology and Molecular Biology Laboratory at O’Bogomolets National Medical University. His academic foundation and professional journey reflect a deep commitment to understanding the interplay between the immune and nervous systems. His research focuses on immunodeficiency diseases, herpesvirus infections, autoimmune neurological disorders, and autistic spectrum disorders. He has introduced original classifications, developed innovative therapies, and contributed significantly to scientific literature, patents, and guidelines. Through global collaborations and membership in leading professional societies, he continues to advance the field of neuroimmunology with impactful, patient-centered solutions.

Academic Profile

Google Scholar

Orcid

Early Academic Pursuits

From the very beginning of his academic journey, Maltsev Dmytro demonstrated a deep fascination with the intricate connections between the immune system and the nervous system. His dedication to medical sciences led him to specialize in neuroimmunology, where he pursued advanced research training and earned a Ph.D. His educational path was marked by a commitment to both theoretical knowledge and practical laboratory skills, shaping a strong foundation for future breakthroughs in immunology and molecular biology.

Professional Endeavors

Maltsev Dmytro serves as the head of the Immunology and Molecular Biology Laboratory at the Research Institute of Experimental and Clinical Medicine, O’Bogomolets National Medical University in Kyiv, Ukraine. In this role, he has successfully guided numerous research initiatives while integrating cutting-edge methodologies such as PCR, ELISA, western blotting, indirect immunofluorescence, and flow laser cytometry. His career reflects a balance between clinical practice, academic leadership, and collaborative scientific inquiry on both national and international platforms.

Contributions and Research Focus

His research spans a wide spectrum of topics, including immunodeficiency diseases, herpesvirus infections, autistic spectrum disorders, autoimmune encephalitis, autoimmune epilepsies, and chronic fatigue syndrome. He has pioneered original classifications for herpesviral encephalitis and primary minor immunodeficiencies, as well as developed innovative therapeutic approaches for immune-related neurological disorders. Currently, he is synthesizing data into a unique multidisciplinary personalized treatment model for children with autistic spectrum disorders, reinforcing his position at the forefront of neuroimmunological research.

Accolades and Recognition

Maltsev Dmytro’s scientific contributions have been widely recognized, with numerous publications in high-impact journals, a strong citation record, and authorship of multiple books. His innovative work in diagnostics and treatment has led to patents that reflect his ability to translate laboratory findings into practical solutions. Membership in prestigious professional organizations such as the European Academy of Neurology further acknowledges his standing as a respected voice in his field.

Impact and Influence

Through his collaborations with leading institutions and experts, including partnerships with the Institute of Neurosurgery in Ukraine and Mayo Clinic in the USA, Maltsev Dmytro has expanded the global reach of his research. His work has influenced diagnostic criteria, therapeutic guidelines, and public health strategies for managing complex immune-related neurological conditions. His scientific findings have inspired both peers and younger researchers to explore innovative solutions in neuroimmunology.

Legacy and Future Contributions

As a thought leader in neuroimmunology, he continues to push the boundaries of understanding immune-nervous system interactions. His dedication to integrating personalized medicine into clinical practice promises a future where treatments for disorders like autism, epilepsy, and encephalitis are more targeted and effective. With ongoing research and an expanding global network, his legacy will be defined by both scientific innovation and meaningful improvements in patient care.

Vision for Advancing Neuroimmunology

Looking ahead, Maltsev Dmytro envisions a future where advanced diagnostics, molecular insights, and individualized therapies converge to transform patient outcomes. His ongoing efforts aim to bridge gaps between research and clinical application, ensuring that scientific progress directly benefits those affected by immune-mediated neurological diseases. Through continuous exploration, mentorship, and global collaboration, he is poised to leave a lasting mark on the landscape of neuroimmunology.

Publication

Clinic, diagnostics and treatment of human herpesvirus infections — VE Kazmirchuk, DV Maltsev — 2009

Diagnosis and treatment of infection caused by the Epstein-Barr virus (human herpes virus type 4): Guidelines — VE Kazmirchuk, DV Maltsev — 2011

Clinical Immunology and Allergology — VE Kazmirchuk, LV Kovalchuk, DV Maltsev — 2009

Clinical immunology and allergology with age-related features — VE Kazmirchuk, LV Kovalchuk, DV Maltsev — 2012

Recommendations for the treatment of human herpesvirus infections — VE Kazmirchuk, DV Maltsev — 2012

The role of cytokines in the detection of functional immune disorders — VE Kazmirchuk, DS Maltsev — 2004

Features of folate cycle disorders in children with ASD — DV Maltsev — 2020

The effectiveness of infliximab in autism spectrum disorders associated with folate cycle genetic deficiency — D Maltsev, L Natrus — 2020

Conclusion

Maltsev Dmytro’s work stands at the intersection of groundbreaking research and clinical innovation, addressing some of the most complex immune-mediated neurological conditions. His ability to merge scientific discovery with practical application has enhanced diagnostic precision and treatment effectiveness worldwide. As he continues to refine personalized therapeutic approaches and expand his global collaborations, his contributions promise to shape the future of neuroimmunology, leaving a lasting legacy of scientific excellence and improved patient outcomes.